The substantial EPS miss and lack of revenue disclosure are bearish signals. Traders should monitor the upcoming Q1 2026 report on May 7 for any signs of revenue recovery or guidance. Given the historical poor performance of prior calls on this ticker, avoid establishing long positions until after the Q1 report.
Price Chart
Executive Summary
Vaxart reported a significant Q4 2025 EPS miss of -$0.10 versus the $0.02 consensus, a 600% negative surprise. No revenue figure was provided in the filing, and the company has announced its Q1 2026 results will be reported on May 7, creating a period of uncertainty.
Key Financial Metrics
Key Facts
- Q4 2025 EPS of -$0.10 missed the $0.02 consensus estimate by 600%.
- No revenue figure was reported in this filing.
- The company announced it will report Q1 2026 financial results on May 7.
- Historical performance shows a 0% win rate at T+20 for prior reports on this ticker, with an average T+20 return of -19.23%.
- Cross-filing actuarial verdicts indicate amplifiers for press-8k-context with press-activist-context and press-offering-context, suggesting heightened sensitivity to this earnings miss.
Financial Impact
EPS miss of -$0.10 vs $0.02 consensus, representing a 600% negative surprise.
Risk Factors
- Continued operational underperformance leading to further EPS misses.
- Potential for negative revenue surprise when Q1 2026 results are released.
- Low liquidity and high volatility typical of OTC-listed biotech stocks.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3285875 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 28, 2026 9w ago | 8-K | $0.4800 $0.5000 | ▲ +4.17% | ▲ +0.79% | $0.4400 (−8.33%) |
Jul 7, 2026 12w ago | 8-K | $0.5500 $0.6000 | ▲ +9.09% | ▲ +5.93% | $0.4400 (−20.00%) |
Jul 6, 2026 12w ago | DEFA14A | $0.6200 $0.5900 | ▼ −4.84% | ▼ −5.69% | $0.4400 (−29.03%) |
Jul 2, 2026 13w ago | DEFA14A | $0.6400 $0.5490 | ▼ −14.22% | ▼ −14.52% | $0.4400 (−31.25%) |
Jul 2, 2026 13w ago | 8-K | $0.6400 $0.5200 | ▼ −18.75% | ▼ −18.34% | $0.4400 (−31.25%) |
Jun 26, 2026 13w ago | DEFA14A | $0.5700 $0.4501 | ▼ −21.04% | ▼ −20.78% | $0.4400 (−22.81%) |
Jun 26, 2026 13w ago | DEFA14A | $0.5700 $0.4501 | ▼ −21.04% | ▼ −20.78% | $0.4400 (−22.81%) |
Jun 26, 2026 13w ago | 8-K | $0.5700 $0.4501 | ▼ −21.04% | ▼ −20.78% | $0.4400 (−22.81%) |
Jun 16, 2026 15w ago | DEFA14A | $0.5600 $0.5300 | ▼ −5.36% | ▼ −6.21% | $0.4400 (−21.43%) |
Jun 8, 2026 16w ago | DEFA14A | $0.5800 $0.5502 | ▼ −5.14% | ▼ −6.53% | $0.4400 (−24.14%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access